NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/17/2026
Back to search
Official data from USPTO
NU.Q
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NU.Q
ST13
US500000079260744Class
1, 5, 10, 42
Filing
79260744
Registration
6044605
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/17/2026
Trademark type
Word
Nice classes
1, 5, 10, 42
Filing date
04/03/2019
Registration date
05/05/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2026
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
78
Owner location
BE
Examiner
BHUPATHI, TARA
Current location
Historical data usage
Holders and representatives
Holders
B. S. (pessoa física)
Representatives
Megan Michaels Crowell & Moring LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and science; chemicals and other chemical preparations used in diagnostics for scientific or research use; chemical reagents for use in industry and science; chemicalbiological and diagnostic reagents for scientific or research usepreparations and substances for scientificdiagnostic and research purposesnamely reagentcellsenzymes; chemical and biological preparations and reagents for use in diagnostic and analytical testsincluding in vitro diagnostic laboratory tests; in vitro diagnostics preparationsdiagnostic reagents for in vitro laboratory use; reagents for life science scientific purposes
Class 5
Pharmaceutical and diagnostic products and preparationspharmaceutical products for the treatment of cancer and cancer diagnostic preparations for medical purposes; medical diagnostic testing materialstest strips for use in the field of cancerreagents and assays for testing bodily fluids for cancer; diagnostic reagents for medical use; diagnostic reagentsreagents for medicinal use; diagnostic reagents for medical use; medical preparations for detection and diagnosis of cancer; medical preparations for detection and diagnosis of inflammation; stem cell differentiation status test preparations for medical purposes in the field of cancer diagnosistestingtreatment; chemicalbiological and diagnostic reagents and preparations for medical purposes in the field of cancer diagnosistestingtreatment; medical preparations for detection and diagnosis of diseases
Class 10
Surgicalmedical and diagnostic apparatus and instrumentscancer diagnostic apparatus and instrumentsmedical apparatus for use in cancer surgery; diagnostic measuring apparatus for medical usediagnostic measuring apparatus for detecting cellular status; medical apparatusinstruments and equipment for use in the detection of cancer; in vitro diagnostic testing apparatus for medical use; in vitro diagnostic testing apparatus incorporating chemical reagentsfor medical use; medical apparatus for testing blood; medical apparatusinstruments and equipment for use in the detection of disease; parts and fittings for all the aforesaid
Class 42
Scientific and technological servicesnamely scientific testing and analysis in the field of the detectiondiagnosis and treatment of cancer; industrial analysis of industrial fluids and industrial research services in the field of the detectiondiagnosis and treatment of cancer; research and developmentconsultancy and advisory services relating to biotechnologymedical technologymedical diagnostic assaysmedical diagnosticsmedical diagnostic reagentssubstancespreparations and materialsdetection of cancer and other diseases; analytical testing and diagnostic servicesnamely providing medical testing services and computer diagnostic servicesall in the field of cancer research and disease classification; design and development of medical diagnostic testing apparatus and reagents; blood analysis services; informationadvisoryconsultancy services relating to all the aforesaid
Publications
History of USPTO decisions and trademark events.
32 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
08/17/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2026
ES71
TEAS SECTION 71 RECEIVED
04/30/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/13/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2020
FIMP
FINAL DISPOSITION PROCESSED
09/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2020
ALIE
ASSIGNED TO LIE
01/16/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/20/2019
RFNT
REFUSAL PROCESSED BY IB
08/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/12/2019
RFRR
REFUSAL PROCESSED BY MPU
07/12/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/25/2019
CNRT
NON-FINAL ACTION WRITTEN
06/24/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/22/2019
DOCK
ASSIGNED TO EXAMINER
06/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/18/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/13/2019
Continuous trademark protection
Get notified about every new filing that threatens NU.Q or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.